Analgesics in the United Kingdom

Euromonitor International's Analgesics in the United Kingdom market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.

Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.

Tables: 30  |  Publication date: Apr 2009
Cost: 
GBP560.00

Why buy this report

  • Get insight into trends in market performance
  • Pinpoint growth sectors and identify factors driving change
  • Identify market and brand leaders and understand the competitive environment

Product coverage

Systemic analgesics; Topical analgesics/anaesthetic

Table of contents

OTC HEALTHCARE IN THE UNITED KINGDOM : MARKET INSIGHT

EXECUTIVE SUMMARY

OTC healthcare market remains stable despite economic slump

Smokers and elderly continue to bolster market

Market remains dominated by megabrands

Shoppers continue to shift to supermarkets

Recession expected to bypass OTC healthcare market

KEY TRENDS AND DEVELOPMENTS

John Bull faces bear market

Fat is the new thin

Consumers cherish their chains

National Stealth Service

MARKET INDICATORS

Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008

Table 2 Life Expectancy at Birth 2003-2008

MARKET DATA

Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008

Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008

Table 5 OTC Healthcare Company Shares by Value 2004-2008

Table 6 OTC Healthcare Brand Shares by Value 2005-2008

Table 7 Penetration of Private Label by Sector 2003-2008

Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008

Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008

Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013

Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013

APPENDIX

Vitamins & Dietary Supplements Registration and Classification

EU Legislation

Self-medication and Preventative Medicine

Generics

Switches

Summary 1 OTC Healthcare Switches 2005-2007

DEFINITIONS

Sources

Summary 2 Research Sources

LOCAL COMPANY PROFILES - UNITED KINGDOM

BAYER PLC - OTC HEALTHCARE - UNITED KINGDOM

STRATEGIC DIRECTION

KEY FACTS

Summary 3 Bayer Plc: Key Facts

Summary 4 Bayer Plc: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 5 Bayer Plc: Competitive Position 2008

GLAXOSMITHKLINE PLC - OTC HEALTHCARE - UNITED KINGDOM

STRATEGIC DIRECTION

KEY FACTS

Summary 6 GlaxoSmithKline Plc: Key Facts

Summary 7 GlaxoSmithKline Plc: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 8 GlaxoSmithKline: Competitive Position 2008

RECKITT BENCKISER PLC - OTC HEALTHCARE - UNITED KINGDOM

STRATEGIC DIRECTION

KEY FACTS

Summary 9 Reckitt Benckiser Plc: Key Facts

Summary 10 Reckitt Benckiser Plc: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 11 Reckitt Benckiser Plc: Competitive Position 2008

ANALGESICS IN THE UNITED KINGDOM

HEADLINES

TRENDS

SWITCHES

COMPETITIVE LANDSCAPE

PROSPECTS

SECTOR DATA

Table 12 Sales of Analgesics by Subsector: Value 2003-2008

Table 13 Sales of Analgesics by Subsector: % Value Growth 2003-2008

Table 14 Herbal vs Standard Topical Analgesics 2003-2008

Table 15 Topical Analgesics by Format: % Value Breakdown 2004-2008

Table 16 Analgesics Company Shares by Value 2004-2008

Table 17 Analgesics Brand Shares by Value 2005-2008

Table 18 Forecast Sales of Analgesics by Subsector: Value 2008-2013

Table 19 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013